drugset / Trial / NCT04472650
Relative Bioavailability of Two Different Capsule Formulations of Sitravatinib in Healthy Adults
RandomizedCrossoverOpen-labelTreatment
Summary
The primary objective of the study was to investigate the relative bioavailability and pharmacokinetics (PK) of sitravatinib free base and malate salt capsule formulations following oral administration in healthy adults.
Timeline
- Start
- 2020-07-23
- Primary completion
- 2020-11-09
- Completion
- 2020-11-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitravatinib | Small molecule | 100 mg | Oral |
| Subject | Sitravatinib | Small molecule | 120 mg | Oral |